🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchTRIUMPH program (retatrutide) — my results so far Page 7

TRIUMPH program (retatrutide) — my results so far

BenResearch_OR Fri, Jan 31, 2025 at 9:18 PM 42 replies 1,987 viewsPage 7 of 9
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Feb 18, 2025 at 5:57 AM#31
FDA_TrackerJim said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Thank you for spelling out the reasoning rather than just the conclusion.

Last edited: Feb 18, 2025 at 6:57 AM
50 23mona_PHX, andrew_nyc, Dr.EndoEP and 47 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Feb 19, 2025 at 5:54 AM#32

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

1 24CryptoCarl
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Feb 20, 2025 at 5:50 AM#33
sophie_paris said:
The useful move here is to separate what is established from what is widely repeated.

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

Last edited: Feb 20, 2025 at 6:50 AM
2 0maria_elpaso, anders_CPH
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Feb 21, 2025 at 5:45 AM#34
sophie_paris said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

3 1matt_MKE, Dr.ReproEndo, lucas_SP_BR
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Feb 22, 2025 at 5:40 AM#35

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

4 2mel_PDX, Dr.AddMedPHL, newstart_MO and 1 other
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register